In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...

Vinay Prasad, a critic of the Food and Drug Administration ... at San Francisco professor and epidemiologist, will replace Peter Marks, whom the Trump administration forced out in late March.

The U.S. FDA has appointed Vinay Prasad to be the next director of its Center for Biologics Evaluation and Research division ...

The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...

The Food and Drug Administration (FDA) has named Indian American hematologist-oncologist Dr. Vinay Prasad, an outspoken ...

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...